Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127973561 | 12797356 | 1 | I | 20160912 | 20160913 | 20160930 | 20160930 | EXP | PHHO2016US013529 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127973561 | 12797356 | 1 | PS | PAZOPANIB | PAZOPANIB | 1 | Oral | 22465 | TABLET | ||||||||||
| 127973561 | 12797356 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 127973561 | 12797356 | 3 | C | PORCINE-MIXACT | 2 | Intravenous (not otherwise specified) | 500 DF, PRN | 0 | 500 | DF | |||||||||
| 127973561 | 12797356 | 4 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 10 ML, PRN | 0 | 10 | ML | ||||||||
| 127973561 | 12797356 | 5 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 325 MG, | 0 | 325 | MG | Q6H | |||||||
| 127973561 | 12797356 | 6 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFFS DAILY | 0 | ||||||||||
| 127973561 | 12797356 | 7 | C | ELIQUIS | APIXABAN | 1 | Oral | 1 DF, BID | 0 | 1 | DF | BID | |||||||
| 127973561 | 12797356 | 8 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, BID | 0 | 4 | MG | BID | |||||||
| 127973561 | 12797356 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127973561 | 12797356 | 10 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Oral | 60 MG, PRN | 0 | 60 | MG | ||||||||
| 127973561 | 12797356 | 11 | C | NEUPOGEN | FILGRASTIM | 1 | Subcutaneous | 0.5 ML, QD | 0 | .5 | ML | QD | |||||||
| 127973561 | 12797356 | 12 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, Q6H | 0 | 1 | DF | Q6H | |||||||
| 127973561 | 12797356 | 13 | C | ADVIL | IBUPROFEN | 1 | Oral | 600 MG, Q6H | 0 | 600 | MG | Q6H | |||||||
| 127973561 | 12797356 | 14 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 150 MCG QD | 0 | ||||||||||
| 127973561 | 12797356 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, Q8H | 0 | 4 | MG | Q8H | |||||||
| 127973561 | 12797356 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127973561 | 12797356 | 17 | C | GLYCOLAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 17 G, FOR 7 DAYS | 0 | ||||||||||
| 127973561 | 12797356 | 18 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, UNK | 0 | ||||||||||
| 127973561 | 12797356 | 19 | C | BACTRIM DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DF, BID | 0 | 1 | DF | BID | |||||||
| 127973561 | 12797356 | 20 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, Q6H | 0 | 50 | MG | Q6H | |||||||
| 127973561 | 12797356 | 21 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 127973561 | 12797356 | 22 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Oral | 2 MG CAPSULE, Q6H | 0 | ||||||||||
| 127973561 | 12797356 | 23 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127973561 | 12797356 | 1 | Ovarian cancer |
| 127973561 | 12797356 | 2 | Ovarian cancer |
| 127973561 | 12797356 | 3 | Heparin neutralisation therapy |
| 127973561 | 12797356 | 4 | Product used for unknown indication |
| 127973561 | 12797356 | 5 | Pyrexia |
| 127973561 | 12797356 | 6 | Hypersensitivity |
| 127973561 | 12797356 | 7 | Product used for unknown indication |
| 127973561 | 12797356 | 8 | Product used for unknown indication |
| 127973561 | 12797356 | 9 | Product used for unknown indication |
| 127973561 | 12797356 | 10 | Product used for unknown indication |
| 127973561 | 12797356 | 11 | Product used for unknown indication |
| 127973561 | 12797356 | 12 | Pain |
| 127973561 | 12797356 | 13 | Pain |
| 127973561 | 12797356 | 14 | Product used for unknown indication |
| 127973561 | 12797356 | 15 | Nausea |
| 127973561 | 12797356 | 16 | Product used for unknown indication |
| 127973561 | 12797356 | 17 | Product used for unknown indication |
| 127973561 | 12797356 | 18 | Product used for unknown indication |
| 127973561 | 12797356 | 19 | Product used for unknown indication |
| 127973561 | 12797356 | 20 | Pain |
| 127973561 | 12797356 | 21 | Insomnia |
| 127973561 | 12797356 | 22 | Diarrhoea |
| 127973561 | 12797356 | 23 | Diarrhoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127973561 | 12797356 | OT |
| 127973561 | 12797356 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127973561 | 12797356 | Dehydration | |
| 127973561 | 12797356 | Hyponatraemia | |
| 127973561 | 12797356 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127973561 | 12797356 | 3 | 20160912 | 20160913 | 0 | |
| 127973561 | 12797356 | 4 | 20160912 | 20160913 | 0 |